Drosophila subobscura isolate 14011-0131.10 chromosome dot, UCBerk_Dsub_1.0, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha; Ephydroidea; Drosophilidae; Drosophila; Sophophora.
REFSEQ INFORMATION: The reference sequence is identical to\nCM017787.1.\nAssembly name: UCBerk_Dsub_1.0\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the UC Berkeley on 2019/08/28.\nThe original whole-genome shotgun project has the accession\nVHIH00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: UC Berkeley\nAssembly Date :: 05-JUN-2019\nAssembly Method :: wtdbg2 v. 2019\nAssembly Name :: UCBerk_Dsub_1.0\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 118.0x\nSequencing Technology :: Oxford Nanopore\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Drosophila subobscura Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 8.4\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC117902905, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC117902905, transcript variant X3
uncharacterized LOC117902905, transcript variant X1
uncharacterized LOC117902905, transcript variant X2
uncharacterized LOC117902905, transcript variant X6
uncharacterized LOC117902905, transcript variant X5
uncharacterized protein LOC117902905 isoform X1
uncharacterized protein LOC117902905 isoform X2
uncharacterized LOC117902902, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC117902902, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC117902902 isoform X1
uncharacterized protein LOC117902902 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC117902903, transcript variant X1
uncharacterized LOC117902903, transcript variant X2
uncharacterized LOC117902903, transcript variant X3
calcium-dependent secretion activator, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
calcium-dependent secretion activator, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
calcium-dependent secretion activator, transcript variant X7
calcium-dependent secretion activator, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
calcium-dependent secretion activator, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
calcium-dependent secretion activator, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium-dependent secretion activator, transcript variant X2
calcium-dependent secretion activator, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
calcium-dependent secretion activator, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
calcium-dependent secretion activator isoform X4
calcium-dependent secretion activator isoform X3
calcium-dependent secretion activator isoform X2
calcium-dependent secretion activator isoform X1
putative dual specificity tyrosine-phosphorylation-regulated kinase 3 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
putative dual specificity tyrosine-phosphorylation-regulated kinase 3 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
putative dual specificity tyrosine-phosphorylation-regulated kinase 3 homolog, transcript variant X3
putative dual specificity tyrosine-phosphorylation-regulated kinase 3 homolog isoform X1
putative dual specificity tyrosine-phosphorylation-regulated kinase 3 homolog isoform X2
uncharacterized LOC117902963, transcript variant X1
uncharacterized LOC117902963, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC117902963 isoform X1
uncharacterized protein LOC117902963 isoform X2
phosphatidylinositol 5-phosphate 4-kinase type-2 beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
phosphatidylinositol 5-phosphate 4-kinase type-2 beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
phosphatidylinositol 5-phosphate 4-kinase type-2 beta, transcript variant X3
phosphatidylinositol 5-phosphate 4-kinase type-2 beta
microphthalmia-associated transcription factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
microphthalmia-associated transcription factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
microphthalmia-associated transcription factor isoform X1
microphthalmia-associated transcription factor isoform X2
microphthalmia-associated transcription factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
microphthalmia-associated transcription factor isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
osmotic avoidance abnormal protein 3, transcript variant X8
osmotic avoidance abnormal protein 3, transcript variant X9
osmotic avoidance abnormal protein 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
osmotic avoidance abnormal protein 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
osmotic avoidance abnormal protein 3, transcript variant X5
osmotic avoidance abnormal protein 3, transcript variant X1
osmotic avoidance abnormal protein 3, transcript variant X2
uncharacterized protein LOC117902960 isoform X8
osmotic avoidance abnormal protein 3 isoform X2
uncharacterized protein LOC117902960 isoform X7
osmotic avoidance abnormal protein 3 isoform X1
uncharacterized protein LOC117902960 isoform X6
osmotic avoidance abnormal protein 3, transcript variant X4
osmotic avoidance abnormal protein 3, transcript variant X3
osmotic avoidance abnormal protein 3 isoform X4
osmotic avoidance abnormal protein 3 isoform X3
glutamate receptor ionotropic, kainate 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glutamate receptor ionotropic, kainate 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
glutamate receptor ionotropic, kainate 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glutamate receptor ionotropic, kainate 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glutamate receptor ionotropic, kainate 2 isoform X1
glutamate receptor ionotropic, kainate 2 isoform X2
glutamate receptor ionotropic, kainate 2 isoform X4
glutamate receptor ionotropic, kainate 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
paired box protein Pax-2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
paired box protein Pax-2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
paired box protein Pax-2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
paired box protein Pax-2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
paired box protein Pax-2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
putative uncharacterized protein DDB_G0277255 isoform X1
paired box protein Pax-2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
putative uncharacterized protein DDB_G0277255 isoform X2
paired box protein Pax-2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
lipoma-preferred partner homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
lipoma-preferred partner homolog, transcript variant X1
lipoma-preferred partner homolog, transcript variant X3
lipoma-preferred partner homolog, transcript variant X4
lipoma-preferred partner homolog isoform X3
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X7
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X1
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X2
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X4
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X5
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X3
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X6
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X7
ATP synthase subunit beta, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
paired box protein Pax-6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
paired box protein Pax-6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 4 gamma 3, transcript variant X2
eukaryotic translation initiation factor 4 gamma 3, transcript variant X3
eukaryotic translation initiation factor 4 gamma 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
eukaryotic translation initiation factor 4 gamma 3, transcript variant X4
eukaryotic translation initiation factor 4 gamma 3 isoform X1
eukaryotic translation initiation factor 4 gamma 3 isoform X2
uncharacterized LOC117902979, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC117902979, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC117902979, transcript variant X6
uncharacterized LOC117902979, transcript variant X8
uncharacterized LOC117902979, transcript variant X7
uncharacterized LOC117902979, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC117902979 isoform X4
uncharacterized protein LOC117902979 isoform X5
uncharacterized protein LOC117902979 isoform X6
uncharacterized protein LOC117902979 isoform X8
uncharacterized protein LOC117902979 isoform X9
uncharacterized protein LOC117902979 isoform X7
uncharacterized LOC117902979, transcript variant X12
uncharacterized LOC117902979, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC117902979, transcript variant X13
uncharacterized LOC117902979, transcript variant X15
uncharacterized LOC117902979, transcript variant X10
uncharacterized LOC117902979, transcript variant X11
uncharacterized LOC117902979, transcript variant X1
uncharacterized LOC117902979, transcript variant X2
uncharacterized LOC117902979, transcript variant X3
uncharacterized protein LOC117902979 isoform X1
uncharacterized protein LOC117902979 isoform X2
uncharacterized protein LOC117902979 isoform X3
uncharacterized protein LOC117902979 isoform X10
uncharacterized protein LOC117902979 isoform X12
uncharacterized protein LOC117902979 isoform X11
uncharacterized protein LOC117902979 isoform X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transcription factor Sox-5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein LOC117902978 isoform X1
transcription factor Sox-5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 26
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC117902946, transcript variant X2
uncharacterized LOC117902946, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC117902946, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC117902946 isoform X1
uncharacterized protein LOC117902946 isoform X2
slo-interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
slo-interacting protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
slo-interacting protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
RNA-binding protein MEX3B, transcript variant X2
RNA-binding protein MEX3B, transcript variant X1
RNA-binding protein MEX3B, transcript variant X5
RNA-binding protein MEX3B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RNA-binding protein MEX3B, transcript variant X3
uncharacterized LOC117902934, transcript variant X2
uncharacterized LOC117902934, transcript variant X1
uncharacterized protein LOC117902934 isoform X1
uncharacterized protein LOC117902934 isoform X2
sodium- and chloride-dependent GABA transporter 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
sodium- and chloride-dependent GABA transporter 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sodium- and chloride-dependent GABA transporter 1 isoform X2
sodium- and chloride-dependent GABA transporter 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ephrin type-B receptor 1-B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ephrin type-B receptor 1-B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ephrin type-B receptor 1-B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ephrin type-B receptor 1-B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ephrin type-B receptor 1-B, transcript variant X2
ephrin type-B receptor 1-B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ephrin type-B receptor 1-B, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
calcium/calmodulin-dependent protein kinase type 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
calcium/calmodulin-dependent protein kinase type 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
calcium/calmodulin-dependent protein kinase type 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
calcium/calmodulin-dependent protein kinase type 1 isoform X1
calcium/calmodulin-dependent protein kinase type 1 isoform X2
uncharacterized LOC117902952, transcript variant X1
uncharacterized LOC117902952, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC117902952, transcript variant X2
uncharacterized protein LOC117902952 isoform X3
uncharacterized protein LOC117902952 isoform X1
uncharacterized protein LOC117902952 isoform X2
uncharacterized LOC117902956, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC117902956, transcript variant X2
tau-tubulin kinase homolog Asator, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
tau-tubulin kinase homolog Asator, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
tau-tubulin kinase homolog Asator, transcript variant X2
tau-tubulin kinase homolog Asator isoform X2
tau-tubulin kinase homolog Asator isoform X3
tau-tubulin kinase homolog Asator isoform X1
zinc finger protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger protein 2, transcript variant X2
zinc finger protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein 2, transcript variant X3
zinc finger protein 2, transcript variant X5
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC117902901
transcriptional activator protein Pur-beta, transcript variant X5
transcriptional activator protein Pur-beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
transcriptional activator protein Pur-beta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
transcriptional activator protein Pur-beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
transcriptional activator protein Pur-beta, transcript variant X4
transcriptional activator protein Pur-alpha isoform X1
transcriptional activator protein Pur-beta isoform X2
transcriptional activator protein Pur-beta isoform X4
transcriptional activator protein Pur-beta isoform X3
NADH-ubiquinone oxidoreductase 49 kDa subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC117902920, transcript variant X5
uncharacterized LOC117902920, transcript variant X1
uncharacterized LOC117902920, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC117902920, transcript variant X3
uncharacterized LOC117902920, transcript variant X4
uncharacterized protein LOC117902920 isoform X1
uncharacterized protein LOC117902920 isoform X2
43 kDa receptor-associated protein of the synapse homolog, transcript variant X2
43 kDa receptor-associated protein of the synapse homolog, transcript variant X3
43 kDa receptor-associated protein of the synapse homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
43 kDa receptor-associated protein of the synapse homolog
protein BCL9 homolog, transcript variant X2
protein BCL9 homolog, transcript variant X1
zinc finger protein 646, transcript variant X2
zinc finger protein 646, transcript variant X1
uncharacterized protein LOC117902985 isoform X1
uncharacterized protein LOC117902985 isoform X2
zinc finger protein 646, transcript variant X3
zinc finger protein 646, transcript variant X4
plasma membrane calcium-transporting ATPase 1, transcript variant X3
plasma membrane calcium-transporting ATPase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
plasma membrane calcium-transporting ATPase 1, transcript variant X5
plasma membrane calcium-transporting ATPase 1, transcript variant X2
plasma membrane calcium-transporting ATPase 1, transcript variant X6
plasma membrane calcium-transporting ATPase 1, transcript variant X4
plasma membrane calcium-transporting ATPase 1, transcript variant X9
plasma membrane calcium-transporting ATPase 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
plasma membrane calcium-transporting ATPase 1, transcript variant X10
plasma membrane calcium-transporting ATPase 1, transcript variant X8
plasma membrane calcium-transporting ATPase 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
plasma membrane calcium-transporting ATPase 1, transcript variant X12
plasma membrane calcium-transporting ATPase 2 isoform X5
plasma membrane calcium-transporting ATPase 2 isoform X8
plasma membrane calcium-transporting ATPase 2 isoform X6
plasma membrane calcium-transporting ATPase 2 isoform X9
plasma membrane calcium-transporting ATPase 2 isoform X7
plasma membrane calcium-transporting ATPase 2 isoform X1
plasma membrane calcium-transporting ATPase 2 isoform X3
plasma membrane calcium-transporting ATPase 2 isoform X2
plasma membrane calcium-transporting ATPase 2 isoform X4
plasma membrane calcium-transporting ATPase 1 isoform X10
plasma membrane calcium-transporting ATPase 1 isoform X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
RING finger protein 11, transcript variant X1
RING finger protein 11, transcript variant X2
zinc transporter ZIP9-B, transcript variant X1
zinc transporter ZIP9-B, transcript variant X2
UV excision repair protein RAD23 homolog B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
nuclear factor 1 A-type, transcript variant X1
nuclear factor 1 A-type, transcript variant X2
nuclear factor 1 A-type, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
rho GTPase-activating protein 6, transcript variant X3
rho GTPase-activating protein 6, transcript variant X1
rho GTPase-activating protein 6, transcript variant X2
rho GTPase-activating protein 6, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC117902982 isoform X1
rho GTPase-activating protein 6 isoform X3
rho GTPase-activating protein 6, transcript variant X4
uncharacterized protein LOC117902982 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
myb-like protein P, transcript variant X11
myb-like protein P, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
myb-like protein P, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
myb-like protein P, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
myb-like protein P, transcript variant X5
myb-like protein P, transcript variant X1
myb-like protein P, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
myb-like protein P, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
myb-like protein P, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
myb-like protein P, transcript variant X10
myb-like protein P, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein LOC117902987 isoform X7
uncharacterized protein LOC117902987 isoform X5
uncharacterized protein LOC117902987 isoform X2
uncharacterized protein LOC117902987 isoform X4
uncharacterized protein LOC117902987 isoform X3
uncharacterized protein LOC117902987 isoform X1
uncharacterized protein LOC117902987 isoform X9
myb-like protein P, transcript variant X8
uncharacterized protein LOC117902987 isoform X6
ADP-ribosylation factor-like protein 4A, transcript variant X2
ADP-ribosylation factor-like protein 4A, transcript variant X1
ADP-ribosylation factor-like protein 4A, transcript variant X3
ADP-ribosylation factor-like protein 4C isoform X3
ADP-ribosylation factor-like protein 4A isoform X2
ADP-ribosylation factor-like protein 4A isoform X1
ATP-binding cassette sub-family D member
tetratricopeptide repeat protein 39B-like, transcript variant X5
tetratricopeptide repeat protein 39B-like, transcript variant X4
tetratricopeptide repeat protein 39B-like isoform X5
tetratricopeptide repeat protein 39B-like, transcript variant X3
tetratricopeptide repeat protein 39B-like, transcript variant X2
tetratricopeptide repeat protein 39B-like, transcript variant X1
tetratricopeptide repeat protein 39B-like isoform X3
tetratricopeptide repeat protein 39B-like isoform X1
tetratricopeptide repeat protein 39B-like isoform X2
tetratricopeptide repeat protein 39B-like isoform X4
uncharacterized LOC117902997, transcript variant X2
uncharacterized LOC117902997, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
probable H/ACA ribonucleoprotein complex subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable cation-transporting ATPase 13A3, transcript variant X1
probable cation-transporting ATPase 13A3, transcript variant X3
probable cation-transporting ATPase 13A3 isoform X1
probable cation-transporting ATPase 13A3 isoform X3
probable cation-transporting ATPase 13A3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
probable cation-transporting ATPase 13A3 isoform X2
uncharacterized LOC117902967, transcript variant X1
uncharacterized LOC117902967, transcript variant X2
uncharacterized protein LOC117902967 isoform X1
uncharacterized protein LOC117902967 isoform X2
forkhead box protein I1, transcript variant X1
forkhead box protein I1, transcript variant X2
uncharacterized protein LOC117902932 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
transcriptional activator cubitus interruptus, transcript variant X2
transcriptional activator cubitus interruptus, transcript variant X1
transcriptional activator cubitus interruptus isoform X2
transcriptional activator cubitus interruptus isoform X1
transcriptional activator cubitus interruptus, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
transcriptional activator cubitus interruptus isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
protein pangolin, isoforms A/H/I/S, transcript variant X10
protein pangolin, isoforms A/H/I/S, transcript variant X9
protein pangolin, isoforms A/H/I/S, transcript variant X8
protein pangolin, isoforms A/H/I/S isoform X5
protein pangolin, isoforms A/H/I/S isoform X6
protein pangolin, isoforms A/H/I/S isoform X7
protein pangolin, isoforms A/H/I/S, transcript variant X7
protein pangolin, isoforms A/H/I/S, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
protein pangolin, isoforms A/H/I/S, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
protein pangolin, isoforms A/H/I/S, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein pangolin, isoforms A/H/I/S, transcript variant X6
protein pangolin, isoforms A/H/I/S, transcript variant X2
protein pangolin, isoforms A/H/I/S, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns